Teva Pharmaceutical Industries Limited

Sicor Inc.

Jirí Faustmann

Judith Aronhime

Alexandr Jegorov

Ales Gavenda

Roman Gabriel

Ondrej Simo

Tamás Koltai

Miloslav Chudík

Jirí Filipcík

Alexandr Martaus

Pavel Vraspir

Pavel Vraspír

Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.

Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form &#x3b1;

The invention provides crystalline forms of isopropyl alcohol solvate of dasatinib, methods for their preparation, and pharmaceutical compositions thereof. 

Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described. The structure diagram below shows the chemical structure of imatinib mesylate. 

The invention provides anhydrous forms of dasatinib, methods for their preparation, and pharmaceutical compositions thereof. 

Anhydrous form of dasatinib and process for preparation thereof

Growing community of inventors

Opava, Czechia

Jirí Faustmann